- Nasal and trans-nasal lung deposition of aerosols
- Spray pattern as a screening tool during early development of nasal sprays
- Point of View: Recommendations to a young scientist to pursue inhalation research
- Meeting expectations for FDA nasal spray Q3 structural equivalence
- Regulatory considerations for cybersecurity and data privacy in digital health and medical applications and products
- Evaluating simulated patient use in realistic nasal airway models for the in vitro characterization of nasal spray products
- Selecting a nasal spray pump
- Overcoming challenges in development of nasal vaccines through intelligent particle engineering
- Nasal spray regulatory approval
- Nasal drug delivery devices: Past, present and future device innovations for the would-be product developer
- Nasal and sublingual spray delivery devices: Market opportunities and unmet medical needs
- Intranasal Vaccines: Protecting Public Safety
- Intranasal vaccination
- In vitro nasal spray characterization
- In vitro bioequivalence testing of nasal sprays
- Human factors studies in the development of a new nasal delivery device
- From actuation to deposition: Particle sizing techniques for characterizing nasal drug delivery systems
- Formulation and characterization of nasal sprays
- Evolution of nasal aerosol products for pain management
- Enhancing drug product portfolios for nasal aerosols and buccal spray delivery systems
- Applying QbD principles to device selection
- Thixotropic sprays: Popular with patients, challenging for developers
- Trends in nasal delivery
- Unit-dose aseptic packaging of nasal drugs
- A “smart” move: The development of electronic devices for nasal aerosols
- In vitro particle deposition in the nasal cavity